Clinical Trial Update: Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing olaparib in combination with paclitaxel for advanced gastric cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Olaparib (Olaparib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-11-07